Evaluation of the human fragile X mental retardation 1 polymerase chain reaction reagents to amplify the FMR1 gene: Testing in a clinical diagnostic laboratory

Genetic Testing and Molecular Biomarkers

Volumn 16, Issue 3, 2012, Pages 187-192

  Nahhas, Fatimah A ^a   Monroe, Thomas J ^b   Prior, Thomas W ^c   Botma, Patricia I ^b   Fang, Jin ^c   Snyder, Pamela J ^c   Talbott, Sandi L ^b   Feldman, Gerald L ^a,d  

^a DETROIT MEDICAL CENTER   (United States)

^b SPECTRUM HEALTH   (United States)

^c OHIO STATE UNIVERSITY   (United States)

^d WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOSINE; FRAGILE X MENTAL RETARDATION PROTEIN; GUANINE; REAGENT;

ALLELE; ARTICLE; CONTROLLED STUDY; FEMALE; FRAGILE X SYNDROME; GENE AMPLIFICATION; GENE MUTATION; GENOTYPE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; METHYLATION; MOSAICISM; POLYMERASE CHAIN REACTION; SOUTHERN BLOTTING;

ALLELES; BLOTTING, SOUTHERN; CLINICAL LABORATORY TECHNIQUES; DNA METHYLATION; ELECTROPHORESIS, CAPILLARY; FEMALE; FRAGILE X MENTAL RETARDATION PROTEIN; FRAGILE X SYNDROME; HUMANS; INDICATORS AND REAGENTS; MALE; MUTATION; POLYMERASE CHAIN REACTION; REAGENT KITS, DIAGNOSTIC; TRINUCLEOTIDE REPEAT EXPANSION;

EID: 84858838876     PISSN: 19450265     EISSN: 19450257     Source Type: Journal    
DOI: 10.1089/gtmb.2011.0128     Document Type: Article

References (26)

1. Bodega B, Bione S, Dalpra L, et al. (2006) Influence of intermediate and uninterrupted FMR1 CGG expansions in premature ovarian failure manifestation. Hum Reprod 21:952-957.
2. Bretherick KL, Fluker MR, Robinson WP (2005) FMR1 repeat sizes in the gray zone and high end of the normal range are associated with premature ovarian failure. Hum Genet 117:376-382.
3. Chen L, Hadd A, Sah S, et al. (2010) An information-rich CGG repeat primed PCR that detects the full range of fragile X expanded alleles and minimizes the need for Southern blot analysis. J Mol Diagn 12:589-600.
4. Chen L, Hadd A, Sah S, et al. (2011) High-resolution methylation polymerase chain reaction for fragile X analysis: Evidence for novel FMR1 methylation patterns undetected in Southern blot analyses. Genet Med 13:528-538.
5. Coffee B, Keith K, Albizua I, et al. (2009) Incidence of fragile X syndrome by newborn screening for methylated FMR1 DNA. Am J Hum Genet 85:503-514.
6. Collins SC, Coffee B, Benke PJ, et al. (2010) Array-based FMR1 sequencing and deletion analysis in patients with a fragile X syndrome-like phenotype. PLoS One 5:e9476.
7. Devys D, Lutz Y, Rouyer N, et al. (1993) The FMR-1 protein is cytoplasmic, most abundant in neurons and appears normal in carriers of a fragile X premutation. Nat Genet 4:335-340.
8. Eichler EE, Holden JJ, Popovich BW, et al. (1994) Length of uninterrupted CGG repeats determines instability in the FMR1 gene. Nat Genet 8:88-94.
9. Feng Y, Gutekunst CA, Eberhart DE, et al. (1997) Fragile X mental retardation protein: Nucleocytoplasmic shuttling and association with somatodendritic ribosomes. J Neurosci 17: 1539-1547.
10. Fernandez-Carvajal I, Lopez Posadas B, Pan R, et al. (2009) Expansion of an FMR1 grey-zone allele to a full mutation in two generations. J Mol Diagn 11:306-310.
11. Filipovic-Sadic S, Sah S, Chen L, et al. (2010) A novel FMR1 PCR method for the routine detection of low abundance expanded alleles and full mutations in fragile X syndrome. Clin Chem 56:399-408.
12. Fu YH, Kuhl DP, Pizzuti A, et al. (1991) Variation of the CGG repeat at the fragile X site results in genetic instability: Resolution of the Sherman paradox. Cell 67:1047-1058.
13. Hantash FM, Goos DG, Tsao D, et al. (2010) Qualitative assessment of FMR1 (CGG)n triplet repeat status in normal, intermediate, premutation, full mutation, and mosaic carriers in both sexes: Implications for fragile X syndrome carrier and newborn screening. Genet Med 12:162-173.
14. Kronquist KE, Sherman SL, Spector EB (2008) Clinical significance of tri-nucleotide repeats in Fragile X testing: A clarification of American College of Medical Genetics guidelines. Genet Med 10:845-847.
15. Ludwig AL, Raske C, Tassone F, et al. (2009) Translation of the FMR1 mRNA is not influenced by AGG interruptions. Nucleic Acids Res 37:6896-6904.
16. Lyon E, Laver T, Yu P, et al. (2010) A Simple, high-throughput assay for fragile X expanded alleles using triple repeat primed PCR and capillary electrophoresis. J Mol Diagn 12:505-511.
17. Nolin SL, Brown WT, Glicksman A, et al. (2003) Expansion of the fragile X CGG repeat in females with premutation or intermediate alleles. Am J Hum Genet 72:454-464.
18. Nygren AO, Lens SI, Carvalho R (2008) Methylation-specific multiplex ligation-dependent probe amplification enables a rapid and reliable distinction between male FMR1 premutation and full-mutation alleles. J Mol Diagn 10:496-501.
19. Oostra BA, Willemsen R (2009) FMR1: A gene with three faces. Biochim Biophys Acta 1790:467-477.
20. Sherman S, Pletcher BA, Driscoll DA (2005) Fragile X syndrome: Diagnostic and carrier testing. Genet Med 7:584-587.
21. Snow K, Doud LK, Hagerman R, et al. (1993) Analysis of a CGG sequence at the FMR-1 locus in fragile X families and in the general population. Am J Hum Genet 53:1217-1228.
22. Strom CM, Crossley B, Redman JB, et al. (2007a) Molecular testing for fragile X syndrome: Lessons learned from 119,232 tests performed in a clinical laboratory. Genet Med 9:46-51.
23. Strom CM, Huang D, Li Y, et al. (2007b) Development of a novel, accurate, automated, rapid, high-throughput technique suitable for population-based carrier screening for Fragile X syndrome. Genet Med 9:199-207.
24. Tassone F, Beilina A, Carosi C, Albertosi S, et al. (2007) Elevated FMR1 mRNA in premutation carriers is due to increased transcription. Rna 13:555-562.
25. Tassone F, Pan R, Amiri K, et al. (2008) A rapid polymerase chain reaction-based screening method for identification of all expanded alleles of the fragile X (FMR1) gene in newborn and high-risk populations. J Mol Diagn 10:43-49.
26. Verkerk AJ, Pieretti M, Sutcliffe JS, et al. (1991) Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome. Cell 65:905-914.